Australien - engelska - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - rosuvastatin calcium, quantity: 10.42 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose; microcrystalline cellulose; crospovidone; light magnesium oxide; titanium dioxide; lactose monohydrate; hypromellose; triacetin; brilliant blue fcf aluminium lake; iron oxide red; quinoline yellow aluminium lake - cavstat 10 should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,prevention of cardiovascular events cavstat 10 is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). cavstat 10 is indicated to:,? reduce the risk of nonfatal myocardial infarction ? reduce the risk of nonfatal stroke ? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia cavstat 10 is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,prior to initiating therapy with cavstat 10, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - alprostadil 10 µg/ml - powder and solvent for solution for injection - 10 µg - alprostadil 10 µg - alprostadil

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 10 µg/dose - suspension for injection - 10 µg/0,5 ml - hepatitis b virus surface antigen, recombinant 10 µg/dose - hepatitis b, purified antigen

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - hepatitis b virus surface antigen (recombinant) 10 µg/dose - suspension for injection - 10 µg/0,5 ml - hepatitis b virus surface antigen, recombinant 10 µg/dose - hepatitis b, purified antigen

Förenade Arabemiraten - engelska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading india - 30's (10's blister x 3) - tablet - 10+20 mg - cardiovascular system-lipid-regulators, cardiovascular system-lipid-regulators

Förenade Arabemiraten - engelska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

muscat pharmaceutical trading india - 30's (10's blister x 3) - tablet - 10 + 10 mg - cardiovascular system-lipid-regulators, cardiovascular system-lipid-regulators

Jordanien - engelska - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الحياة للصناعات الدوائية - hayat pharmaceutical industries co.plc - cholecalciferol 10.000 iu - 10.000 iu

Jordanien - engelska - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الحياة للصناعات الدوائية - hayat pharmaceutical industries co.plc - cholecalciferol 10.000 iu - 10.000 iu

Förenade Arabemiraten - engelska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

unicare medical trading l.l.c jordan - 30’s (10’s blister x 3) - tablet - 10/160/12.5 mg/tablet - cardiovascular system-hypertension , heart failure

Förenade Arabemiraten - engelska - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

unicare medical trading l.l.c jordan - 30’s (10’s blister x 3) - tablet - 10/160/25 mg/tablet - cardiovascular system-hypertension , heart failure